250 related articles for article (PubMed ID: 4927902)
1. Immunological aspects of neoplasia: a rational basis for immunotherapy.
Ann Intern Med; 1971 Apr; 74(4):587-604. PubMed ID: 4927902
[No Abstract] [Full Text] [Related]
2. Immunological studies with human neoplasms.
Morton DL
J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
[No Abstract] [Full Text] [Related]
3. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.
Morton DL; Eilber FR; Joseph WL; Wood WC; Trahan E; Ketcham AS
Ann Surg; 1970 Oct; 172(4):740-9. PubMed ID: 5272336
[No Abstract] [Full Text] [Related]
4. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
Morton DL; Eilber FR; Malmgren RA
Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
[No Abstract] [Full Text] [Related]
5. Immunology and the melanomas.
Lewis MG
Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
[No Abstract] [Full Text] [Related]
6. [Tumor immunology. Introduction and technic; immune reactions to chemically induced tumors].
Oettgen HF; Gallmeier WM
Dtsch Med Wochenschr; 1968 May; 93(21):1072-8. PubMed ID: 4872858
[No Abstract] [Full Text] [Related]
7. Studies of humoral and cell-mediated immunity in human melanoma.
Mukherji B; Nathanson L; Clark DA
Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
[No Abstract] [Full Text] [Related]
8. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
Cohen AM; Millar RC; Ketcham AS
Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
[No Abstract] [Full Text] [Related]
9. Possibilities and problems of immunologic intervention in cancer.
Smith RT
N Engl J Med; 1972 Aug; 287(9):439-50. PubMed ID: 4558044
[No Abstract] [Full Text] [Related]
10. A guinea pig model for tumor immunology. A summary.
Rapp HJ
Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
[No Abstract] [Full Text] [Related]
11. A study in clinical cancer immunotherapy.
Hughes LE; Kearney R; Tully M
Cancer; 1970 Aug; 26(2):269-78. PubMed ID: 4988972
[No Abstract] [Full Text] [Related]
12. Soluble mouse histocompatibility antigens.
Koene R; McKenzie IF; Painter E; Sachs DH; Winn HJ; Russell PS
Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
[No Abstract] [Full Text] [Related]
13. Quality, affinity, and class A antibody produced after partial tolerance induction.
Liacopoulos P; Harel S; Efraim SB
Transplant Proc; 1972 Sep; 4(3):391-4. PubMed ID: 5080605
[No Abstract] [Full Text] [Related]
14. Tumour-associated antigens and tumour-host interactions.
Baldwin RW
Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
[No Abstract] [Full Text] [Related]
15. Immunotherapy of human melanomas and sarcomas.
Morton DL
Natl Cancer Inst Monogr; 1972 Dec; 35():375-8. PubMed ID: 4659050
[No Abstract] [Full Text] [Related]
16. Failure of immunocytoadherence to demonstrate delayed hypersensitivity.
Roberts CI; Brandriss MW; Vaughan JH
J Immunol; 1971 Apr; 106(4):1056-64. PubMed ID: 5553713
[No Abstract] [Full Text] [Related]
17. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
18. Horizons in tumor immunology. A seminar.
Wilson RE; Alexander P; Rosenberg SA; Simmons RL
Arch Surg; 1974 Jul; 109(1):17-29. PubMed ID: 4834133
[No Abstract] [Full Text] [Related]
19. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
[No Abstract] [Full Text] [Related]
20. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
